The role of botulinum neurotoxin in pain management--an ongoing controversy.
Ashkenazi
Avi
A
aashkenazi2001@yahoo.com
D000700:Analgesics / Q000008:administration & dosage / Q000627:therapeutic use*; D000818:Animals; D001905:Botulinum Toxins / Q000008:administration & dosage / Q000502:physiology* / Q000627:therapeutic use*; D002908:Chronic Disease; D002986:Clinical Trials as Topic / Q000379:methods; D019468:Disease Management; D006801:Humans; D009498:Neurotoxins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology / Q000523:psychology
D000700:Analgesics; D009498:Neurotoxins; D001905:Botulinum Toxins